Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2019	Dec. 31, 2018
Current Assets:
Cash and cash equivalents	$ 617.9	$ 542.8
Accounts receivable, less allowance for doubtful accounts	1,363.9	1,275.8
Inventories	2,385.0	2,256.5
Prepaid expenses and other current assets	357.1	352.3
Total Current Assets	4,723.9	4,427.4
Property, plant and equipment, net	2,077.4	2,015.4
Goodwill	9,599.7	9,594.4
Intangible assets, net	7,257.6	7,684.6
Other assets	980.1	405.0
Total Assets	24,638.7	24,126.8
Current Liabilities:
Accounts payable	400.9	362.6
Income taxes payable	126.7	142.4
Other current liabilities	1,413.9	1,391.3
Current portion of long-term debt	1,500.0	525.0
Total Current Liabilities	3,441.5	2,421.3
Deferred income taxes, net	840.1	999.5
Long-term income tax payable	685.1	666.2
Other long-term liabilities	557.8	350.0
Long-term debt	6,721.4	8,413.7
Total Liabilities	12,245.9	12,850.7
Commitments and Contingencies (Note 20)
Stockholders' Equity:
Common stock, $0.01 par value, one billion shares authorized, 309.9 million (307.9 million in 2018) issued	3.1	3.1
Paid-in capital	8,920.1	8,686.1
Retained earnings	10,427.3	9,491.2
Accumulated other comprehensive loss	(241.9)	(187.4)
Treasury stock, 103.9 million shares (103.9 million shares in 2018)	(6,720.5)	(6,721.7)
Total Zimmer Biomet Holdings, Inc. stockholders' equity	12,388.1	11,271.3
Noncontrolling interest	4.7	4.8
Total Stockholders' Equity	12,392.8	11,276.1
Total Liabilities and Stockholders' Equity	$ 24,638.7	$ 24,126.8